Imatinib ameliorates bronchiolitis obliterans via inhibition of fibrocyte migration and differentiation

Imatinib prevents airway luminal obstruction by inhibiting the migration and differentiation of fibrocytes. Fibrocytes may be a novel target in the prevention and treatment of BO.